Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis

Fig. 2

The expression levels of METTL7B in the human pan-cancer dataset. A METTL7B expression in 31 normal human tissues in the GTEx data set. B METTL7B expression in 21 tumor cells in the CCLE dataset. C Differential expression of METTL7B in normal tissues and cancers in TCGA datasets. D METTL7B was significantly upregulated in 22 cancer types from the TCGA and GTEx databases (*P < 0.05, **P < 0.01, and ***P < 0.001)

Back to article page